drugset / Trial / NCT00274768

Capecitabine in Treating Patients With Metastatic Breast Cancer

NCT00274768 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well capecitabine works in treating patients with metastatic breast cancer.

Timeline

Start
2004-04
Primary completion
2009-12
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 3000 mg Oral

Indications